VivoSeq
Other

Genetic Polymorphism

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Genetic Polymorphism is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Merck & Co. logo

Merck & Co.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

26

clinical trials

Completed17 · 65%
Unknown status5 · 19%
Active, not recruiting2 · 8%
Recruiting1 · 4%
Terminated1 · 4%

Clinical Trials

Trial Activity

26 trials

Evaluation of IL 12B Genetic Polymorphism (rs3213094)
Recruiting·SSouth Valley University·N/A·NCT07128472·40 enrolled
Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS
Active, not recruiting·—·Phase 4·NCT05680805·100 enrolled
The Effect of Genetic Polymorphisms on the Success of Vital Pulp Therapy
Active, not recruiting·—·N/A·NCT07130214·96 enrolled
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
Completed·IIcahn School of Medicine at Mount Sinai·N/A·NCT00900744·121 enrolled
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
Completed·—·Phase 1·NCT00973986·20 enrolled
Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics
Completed·IIndiana University·N/A·NCT00668395·73 enrolled
Effects of Sildenafil in Resistant Hypertensives and Genetic Polymorphism
Completed·UUniversity of Campinas, Brazil·N/A·NCT01392638·120 enrolled
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
Completed·—·Phase 4·NCT01340326·800 enrolled
Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression
Completed·CCentre for Addiction and Mental Health·N/A·NCT00517764·299 enrolled
The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers
Completed·IInje University·N/A·NCT01482117·28 enrolled
Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-gene
Completed·MMax-Planck-Institute of Psychiatry·N/A·NCT00550485·79 enrolled
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
Completed·IInje University·Phase 1·NCT00767598·21 enrolled
-Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms
Completed·PParc de Salut Mar·Phase 1·NCT01447472·27 enrolled
CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing
Completed·NNational Taiwan University Hospital·Phase 4·NCT00354757·200 enrolled
Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6
Completed·—·N/A·NCT03054220·34 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)